Skip to content

GreenLight Biosciences Holdings, PBC

Delisted

CIK 1822691fmd_1F5MH12A9J3BD23H3SKP0AYQ09Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 02, 2020 to Mar 31, 2023, 11 periods

Latest annual · FY2022

Millions
Total revenues
7
Operating income
(164)
Net income
(167)
Free cash flow
(163)

Latest quarter · Q1 FY2023

Millions
Total revenues
4
Operating income
(28)
Net income
(28)
Free cash flow
(33)
Open Financials

GreenLight Biosciences Holdings, PBC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$6.8 million$1.6 million+325.1%10-K 2023-03-28 · proof
Operating income-$163.9 million-$108.6 million10-K 2023-03-28 · proof
Net income-$167.1 million-$112.3 million10-K 2023-03-28 · proof
Cash from operating activities-$136.7 million-$91.8 million10-K 2023-03-28 · proof
Free cash flow-$163.3 million-$107 million10-K 2023-03-28 · proof
Total assets$148.6 million$63.1 million+135.7%10-K 2023-03-28 · proof
Total liabilities$100.5 million$93 million+8.1%10-K 2023-03-28 · proof
Cash and cash equivalents$68.1 million$31.4 million+116.6%10-K 2023-03-28 · proof
What was GreenLight Biosciences Holdings, PBC's revenue in fiscal 2022?
GreenLight Biosciences Holdings, PBC reported revenue of $6.8 million for fiscal 2022 (the year ended Dec 31, 2022), against $1.6 million the year before (+325.1%). Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What was GreenLight Biosciences Holdings, PBC's operating income in fiscal 2022?
GreenLight Biosciences Holdings, PBC reported operating income of -$163.9 million for fiscal 2022 (the year ended Dec 31, 2022), against -$108.6 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What was GreenLight Biosciences Holdings, PBC's net income in fiscal 2022?
GreenLight Biosciences Holdings, PBC reported net income of -$167.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$112.3 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What was GreenLight Biosciences Holdings, PBC's cash from operating activities in fiscal 2022?
GreenLight Biosciences Holdings, PBC reported cash from operating activities of -$136.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$91.8 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What was GreenLight Biosciences Holdings, PBC's free cash flow in fiscal 2022?
GreenLight Biosciences Holdings, PBC reported free cash flow of -$163.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$107 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What are GreenLight Biosciences Holdings, PBC's total assets?
As of Dec 31, 2022, GreenLight Biosciences Holdings, PBC reported total assets of $148.6 million, against $63.1 million a year earlier (+135.7%). Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What are GreenLight Biosciences Holdings, PBC's total liabilities?
As of Dec 31, 2022, GreenLight Biosciences Holdings, PBC reported total liabilities of $100.5 million, against $93 million a year earlier (+8.1%). Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What are GreenLight Biosciences Holdings, PBC's cash and cash equivalents?
As of Dec 31, 2022, GreenLight Biosciences Holdings, PBC reported cash and cash equivalents of $68.1 million, against $31.4 million a year earlier (+116.6%). Source: the 10-K filed with the SEC on Mar 28, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1822691&period_type=annual&limit=5"

Information only, not investment advice.